Interphex

Kindeva, a global CDMO and drug delivery expert, has appointed Daniel J. Speciale as Chief Financial Officer (CFO) to strengthen its executive leadership team and drive financial strategy across the organization.

Speciale will oversee all financial functions, ensuring strong fiscal management, strategic investments, and sustainable business expansion.

“At a time of significant transformation and growth, having a strong financial leader is critical to our success. Dan’s extensive expertise in corporate finance, investor relations, and strategic planning will be invaluable as we continue to innovate and expand our global footprint. His leadership will help drive financial excellence, optimize operational efficiency, and maximize value for our stakeholders,” said Milton Boyer, CEO of Kindeva.

Experience

Speciale has nearly 20 years of financial leadership experience and deep healthcare and pharmaceutical expertise. Most recently, he served as Senior Vice President, Finance, Controller, and Chief Accounting Officer at Vantive. Previously, he held senior financial roles at Mallinckrodt, including Senior Vice President, Finance and CFO of the Specialty Generics division. He began his career in the assurance practice at PricewaterhouseCoopers LLP.

Speciale holds a Bachelor of Science in Accountancy and a Master of Accounting Science degree from the Gies College of Business at the University of Illinois Urbana-Champaign.

Commenting on his appointment, Speciale said, “I look forward to joining Kindeva at such a dynamic time in its journey. Financial discipline, strategic investment, and operational efficiency are critical in today’s evolving market. I look forward to joining the company and working with the leadership team to drive sustainable growth and long-term success.”